Hongru Wang
1665 Kongjiang Road
Shanghai, 200092, China
Shanghai, 200092, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Celastrol induces ferroptosis in ccRCC through TEF-Driven ACOX2 upregulation and metabolic reprogramming.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 10, 2025
Disulfidptosis induced by intermittent fasting and metformin enhances the efficacy of anti-PD-1 therapy in renal cancer.
Journal: Cell communication and signaling : CCS
Published: November 03, 2025
Structural variation drives enhancer hijacking via 3D genome disruption in ccRCC.
Journal: NPJ digital medicine
Published: August 12, 2025
PBRM1 Deficiency Reshapes an Immune Suppressive Microenvironment Through Epigenetic Tuning of PBRM1-KDM5C-IL6 Axis in ccRCC.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 08, 2025
Engineering topological chiral transport in a flat-band lattice of ultracold atoms.
Journal: Light, science & applications
Published: June 24, 2025
Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT/mTOR signaling pathway.
Journal: Cancer cell international
Published: April 21, 2023
Construction and validation of a prognostic model for predicting clear cell renal cell carcinoma based on complement-related genes.
Journal: Translational andrology and urology
Published: March 03, 2023
GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma.
Journal: Molecular carcinogenesis
Published: March 14, 2022
FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Journal: BMC cancer
Published: June 28, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026